AstraZeneca has withdrawn a US licence application for its biologic respiratory treatment motavizumab in a move that will cost the …
Pfizer has established a new network of research partnerships with its Global Centers for Therapeutic Innovation. The Centers is a …
Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …
I paid my visit to MedImmune’s UK headquarters in Cambridge only days after its parent company AstraZeneca announced the closure …
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

